• Japanese
  • Korean
  • Chinese
Home > Pharmaceutical > Cancer Market Research Reports
Category
Pharmaceutical (6614)
Biologics (265)
Biomarker (100)
Cancer (1048)
Diabetes (181)
Drug Delivery System (139)
Drug Discovery (2209)
Drug Regulation (130)
Gene Therapeutics & RNAi (89)
Generic Drugs (96)
Genome-based Drug Discovery (145)
Infectious Disease (330)
Molecular Targeted Therapeutics (201)
Neurodegenerative Disease (230)
OTC Drug (103)
Personalized Medicine (58)
Pharmaceutical Companies (859)
Prescription Drugs (473)
Regenerative Medicine (133)
Vaccines (222)

Cancer Market Research Reports

Our selection of research reports in this category can supply in-depth information regarding existing and emerging cancer diagnostics and therapies. They assess the impact of drug development pipelines, patent expiry, partnerships, and emerging tools and developments. Over 500 reports are available.

Filter
Title Search
1 - 25 of 1048 Products Sort by Display
*
Product code:258887
Published by Venture Planning Group
Published August 28, 2014 Price USD 4200
Content info 567 Pages
Sample available
*
Product code:237646
Published by Venture Planning Group
Published August 26, 2014 Price USD 3500
Content info 278 Pages
Sample available
*
Product code:166153
Published by Venture Planning Group
Published August 26, 2014 Price USD 2800
Content info 250 Pages
Sample available
This report presents a detailed analysis of the CEA testing market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan, including clinical significance and current laboratory practice; 5- and 10-year test volume....
EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023
Product code:311413
Published by GlobalData
Published August 25, 2014 Price USD 3995
Content info 43 Pages
Sample available
OpportunityAnalyzer: Non-Hodgkin's B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018
Product code:311411
Published by GlobalData
Published August 25, 2014 Price USD 5995
Content info 178 Pages
Sample available
*
Product code:282134
Published by Venture Planning Group
Published August 22, 2014 Price USD 6400
Content info 620 Pages
Sample available
*
Product code:282133
Published by Venture Planning Group
Published August 22, 2014 Price USD 4350
Content info 565 Pages
Sample available
*
Product code:282131
Published by Venture Planning Group
Published August 22, 2014 Price USD 4900
Content info 590 Pages
Sample available
*
Product code:282129
Published by Venture Planning Group
Published August 22, 2014 Price USD 4350
Content info 570 Pages
Sample available
*
Product code:282127
Published by Venture Planning Group
Published August 22, 2014 Price USD 12800
Content info 820 Pages
Sample available
*
Product code:282126
Published by Venture Planning Group
Published August 22, 2014 Price USD 21100
Content info 1200 Pages
Sample available
Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM
Product code:310994
Published by GBI Research
Published August 20, 2014 Price USD 4995
Content info 105 Pages
Sample available
Medical Affairs Reputations in Oncology: Oncologists Rate Key Products and Companies
Product code:310626
Published by Doctor's Guide Publishing Limited (FirstWord Pharma)
Published August 14, 2014 Price USD 3900
Content info 54 Pages
Sample available
Tremor Global Clinical Trials Review, H2, 2014
Product code:310344
Published by GlobalData
Published August 12, 2014 Price USD 2500
Content info 61 Pages
Sample available
Global Hodgkins Lymphoma Therapeutics Market 2014-2018
Product code:310041
Published by Infiniti Research Limited (Technavio)
Published August 6, 2014 Price USD 2500
Content info 79 Pages
Sample available
Cancer Monoclonal Antibody Partnering Terms and Agreements
Product code:238158
Published by Current Partnering, a division of Wildwood Ventures Limited
Published August 5, 2014 Price USD 1995
Content info 630 Pages
Sample available
Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014
Product code:311225
Published by PNS Pharma
Published August 1, 2014 Price USD 2000
Content info 556 Pages
Sample available
Oncology Deals and Alliances of 2013
Product code:295821
Published by Current Partnering, a division of Wildwood Ventures Limited
Published August 1, 2014 Price USD 1495
Content info  
Sample available
Solid Tumor Partnering 2009-2014
Product code:233914
Published by Current Partnering, a division of Wildwood Ventures Limited
Published August 1, 2014 Price USD 995
Content info  
Sample available
*
Product code:233913
Published by Current Partnering, a division of Wildwood Ventures Limited
Published August 1, 2014 Price USD 995
Content info  
Sample available
Pancreatic Cancer Partnering 2009-2014
Product code:233912
Published by Current Partnering, a division of Wildwood Ventures Limited
Published August 1, 2014 Price USD 995
Content info  
Sample available
Ovarian Cancer Partnering 2009-2014
Product code:233911
Published by Current Partnering, a division of Wildwood Ventures Limited
Published August 1, 2014 Price USD 995
Content info  
Sample available
Multiple Myeloma Partnering 2009-2014
Product code:233910
Published by Current Partnering, a division of Wildwood Ventures Limited
Published August 1, 2014 Price USD 995
Content info  
Sample available
Lymphoma Partnering 2009-2014
Product code:233909
Published by Current Partnering, a division of Wildwood Ventures Limited
Published August 1, 2014 Price USD 995
Content info  
Sample available
Lung Cancer Partnering 2009-2014
Product code:233908
Published by Current Partnering, a division of Wildwood Ventures Limited
Published August 1, 2014 Price USD 995
Content info  
Sample available